India to Australia: Hydroxychloroquine Export Trade Route

The India to Australia Hydroxychloroquine corridor is one of India's established pharmaceutical export routes, with 14 shipments documented worth a combined $1.1M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 93% of all export value, reflecting the consolidated nature of India's hydroxychloroquine manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $76.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 18.6%, placing it at rank #12 among India's top hydroxychloroquine export destinations globally.

On the import side, key buyers of Indian hydroxychloroquine in Australia include TO THE ORDER, IA, NA and 4 others. TO THE ORDER is the single largest importer with 6 shipments valued at $295.9K USD.

India's hydroxychloroquine exports to Australia are driven primarily by a handful of large-scale manufacturers. IPCA LABORATORIES LIMITED with 13 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — IPCA LABORATORIES LIMITED, IPCA LABORATORIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $76.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicines:apo-apo-hydroxychloroquine 200mg tabletshydroxychloroquine sulfate tablets43890x1x100's pack=43890 and harmless medicines:apo - hydroxychloroquine 200mg(hydroxychloroquine sulfate tablets)(28668x1x100's pack=2866800 tablets, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER is the largest importer with 6 shipments worth $295.9K USD — representing 28% of all hydroxychloroquine imports from India on this route. A total of 7 buyers are active on this corridor.